{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:37:16Z","timestamp":1792442236913,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory pain is a major clinical challenge, yet appropriate human models mimicking local infection are lacking. We established a human pain model based on intradermal administration of lipopolysaccharide, a component of Gram-negative bacteria, and investigated the time course and underlying molecular mechanisms of inflammatory pain hypersensitivity. A placebo-controlled pilot study with 12 healthy subjects showed that intradermal lipopolysaccharide injection induces hyperaemia peaking at 4.5\u2009h and mechanical hypersensitivity peaking at 6\u2009h. Hypersensitivity to increasingly acidic injections and mechanical pinch lasts longer than hyperaemia. The double-blind, randomised, placebo-controlled full crossover main study (NCT07092215) included 40 healthy subjects and investigated the role of the Receptor for Advanced Glycation End-products. The primary hypothesis was: \u2018The blood flow is different in lipopolysaccharide-injected skin spots compared to lipopolysaccharide-injected skin spots where azeliragon is co-injected\u2019. The two secondary hypotheses were: \u2018Acid-induced pain is different in lipopolysaccharide-injected skin spots compared to lipopolysaccharide-injected skin spots where azeliragon is co-injected\u2019 and \u2018Mechanical pinch-induced pain is different in lipopolysaccharide-injected skin spots compared to lipopolysaccharide-injected skin spots where azeliragon is co-injected\u2019. Co-injection of the respective antagonist azeliragon largely reduces lipopolysaccharide-induced hyperaemia (\u221287%) and significantly attenuates hypersensitivity to mechanical (\u221255%) and increasingly acidic stimuli (\u221240%). In contrast, the Toll-like receptor 4 antagonist resatorvid has no effect on these readouts. In both na\u00efve and inflamed skin, the TRPV1 antagonist BCTC inhibits the majority of acid-induced pain. Lipopolysaccharide-induced inflammation causes a substantial shift in the pH sensitivity of pain, suggesting that even mild tissue acidification contributes to inflammatory pain. The human lipopolysaccharide skin inflammation model depends largely on the Receptor for Advanced Glycation End-products, highlighting its potential as a target in inflammation.<\/jats:p>","DOI":"10.1038\/s41467-026-76771-2","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:31Z","timestamp":1788371071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RAGE mediates LPS-induced inflammatory pain in human skin \u2013 a double-blind, randomised, placebo-controlled full crossover study"],"prefix":"10.1038","volume":"17","author":[{"given":"Felix J.","family":"Resch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Pramhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Sator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-0442","authenticated-orcid":false,"given":"Stefan","family":"Heber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-7066","authenticated-orcid":false,"given":"Michael J. M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"76771_CR1","first-page":"203","volume":"5","author":"CD M\u00f8rch","year":"2013","unstructured":"M\u00f8rch, C. D., Gazerani, P., Nielsen, T. A. & Arendt-Nielsen, L. The UVB cutaneous inflammatory pain model: a reproducibility study in healthy volunteers. Int. J. Physiol. Pathophysiol. Pharmacol. 5, 203\u2013215 (2013).","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"76771_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/papr.12267","volume":"16","author":"T Andresen","year":"2016","unstructured":"Andresen, T. et al. Intradermal injection with nerve growth factor: a reproducible model to induce experimental allodynia and hyperalgesia. Pain. Pract. 16, 12\u201323 (2016).","journal-title":"Pain. Pract."},{"key":"76771_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/clpt.1991.212","volume":"50","author":"DC Manning","year":"1991","unstructured":"Manning, D. C., Raja, S. N., Meyer, R. A. & Campbell, J. N. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin. Pharmacol. Ther. 50, 721\u2013729 (1991).","journal-title":"Clin. Pharmacol. Ther."},{"key":"76771_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/brain\/117.2.385","volume":"117","author":"S Kilo","year":"1994","unstructured":"Kilo, S., Schmelz, M., Koltzenburg, M. & Handwerker, H. O. Different patterns of hyperalgesia induced by experimental inflammation in human skin. Brain 117, 385\u2013396 (1994).","journal-title":"Brain"},{"key":"76771_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3959(97)00160-7","volume":"74","author":"JL Pedersen","year":"1998","unstructured":"Pedersen, J. L. & Kehlet, H. Hyperalgesia in a human model of acute inflammatory pain: a methodological study. Pain 74, 139\u2013151 (1998).","journal-title":"Pain"},{"key":"76771_CR6","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2174\/092986708784872393","volume":"15","author":"AS Andreasen","year":"2008","unstructured":"Andreasen, A. S. et al. Human endotoxemia as a model of systemic inflammation. Curr. Med. Chem. 15, 1697\u20131705 (2008).","journal-title":"Curr. Med. Chem."},{"key":"76771_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/cpt.70126","volume":"119","author":"MCE van Ruissen","year":"2026","unstructured":"van Ruissen, M. C. E. et al. Breaking barriers: characterization of the intradermal lipopolysaccharide challenge as an in vivo model for controlled induction of vascular leakage in healthy volunteers. Clin. Pharmacol. Ther. 119, 678\u2013687 (2026).","journal-title":"Clin. Pharmacol. Ther."},{"key":"76771_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/cpt.2516","volume":"111","author":"TP Buters","year":"2022","unstructured":"Buters, T. P. et al. Clinical, cellular, and molecular effects of corticosteroids on the response to intradermal lipopolysaccharide administration in healthy volunteers. Clin. Pharmacol. Ther. 111, 964\u2013971 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"76771_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/bcp.14999","volume":"88","author":"TP Buters","year":"2022","unstructured":"Buters, T. P. et al. Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers. Br. J. Clin. Pharmacol. 88, 680\u2013690 (2022).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"76771_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1189\/jlb.0512250","volume":"93","author":"A Basran","year":"2013","unstructured":"Basran, A. et al. Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines. J. Leukoc. Biol. 93, 7\u201319 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"76771_CR11","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.cell.2024.03.001","volume":"187","author":"E Granton","year":"2024","unstructured":"Granton, E. et al. Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection. Cell 187, 1874\u20131888.e14 (2024).","journal-title":"Cell"},{"key":"76771_CR12","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"76771_CR13","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","volume":"186","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto, Y. et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J. Immunol. 186, 3248\u20133257 (2011).","journal-title":"J. Immunol."},{"key":"76771_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86069-6","volume":"11","author":"M Nair","year":"2021","unstructured":"Nair, M. et al. Lipopolysaccharides induce a RAGE-mediated sensitization of sensory neurons and fluid hypersecretion in the upper airways. Sci. Rep. 11, 8336 (2021).","journal-title":"Sci. Rep."},{"key":"76771_CR15","doi-asserted-by":"publisher","first-page":"e76039","DOI":"10.1371\/journal.pone.0076039","volume":"8","author":"B Nativel","year":"2013","unstructured":"Nativel, B. et al. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PLoS ONE 8, e76039 (2013).","journal-title":"PLoS ONE"},{"key":"76771_CR16","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori, O. et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752\u201325761 (1995).","journal-title":"J. Biol. Chem."},{"key":"76771_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1667620","volume":"12","author":"H Lin","year":"2025","unstructured":"Lin, H. et al. Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing. Front. Med. 12, 1667620 (2025).","journal-title":"Front. Med."},{"key":"76771_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brainresbull.2023.03.010","volume":"197","author":"X Zhao","year":"2023","unstructured":"Zhao, X., Wang, N., Li, Z. & Li, L. Knockdown of PAC1 improved inflammatory pain in mice by regulating the RAGE\/TLR4\/NF-\u03baB signaling pathway. Brain Res. Bull. 197, 49\u201356 (2023).","journal-title":"Brain Res. Bull."},{"key":"76771_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.it.2023.08.008","volume":"44","author":"S Hajjar","year":"2023","unstructured":"Hajjar, S. & Zhou, X. pH sensing at the intersection of tissue homeostasis and inflammation. Trends Immunol. 44, 807\u2013825 (2023).","journal-title":"Trends Immunol."},{"key":"76771_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/emboj.2011.19","volume":"30","author":"E Aneiros","year":"2011","unstructured":"Aneiros, E. et al. The biophysical and molecular basis of TRPV1 proton gating. EMBO J. 30, 994\u20131002 (2011).","journal-title":"EMBO J."},{"key":"76771_CR21","doi-asserted-by":"publisher","first-page":"20280","DOI":"10.1074\/jbc.M113.479337","volume":"288","author":"J de la Roche","year":"2013","unstructured":"de la Roche, J. et al. The molecular basis for species-specific activation of human TRPA1 protein by protons involves poorly conserved residues within transmembrane domains 5 and 6. J. Biol. Chem. 288, 20280\u201320292 (2013).","journal-title":"J. Biol. Chem."},{"key":"76771_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrn3529","volume":"14","author":"JA Wemmie","year":"2013","unstructured":"Wemmie, J. A., Taugher, R. J. & Kreple, C. J. Acid-sensing ion channels in pain and disease. Nat. Rev. Neurosci. 14, 461\u2013471 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"76771_CR23","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/j.pain.0000000000001848","volume":"161","author":"S Heber","year":"2020","unstructured":"Heber, S. et al. TRPV1 antagonist BCTC inhibits pH 6.0-induced pain in human skin. Pain 161, 1532\u20131541 (2020).","journal-title":"Pain"},{"key":"76771_CR24","doi-asserted-by":"publisher","first-page":"102870","DOI":"10.1016\/j.ceca.2024.102870","volume":"119","author":"TKE Maximiano","year":"2024","unstructured":"Maximiano, T. K. E., Carneiro, J. A., Fattori, V. & Verri, W. A. TRPV1: receptor structure, activation, modulation and role in neuro-immune interactions and pain. Cell Calcium 119, 102870 (2024).","journal-title":"Cell Calcium"},{"key":"76771_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jpain.2016.12.011","volume":"18","author":"MG Schwarz","year":"2017","unstructured":"Schwarz, M. G., Namer, B., Reeh, P. W. & Fischer, M. J. M. TRPA1 and TRPV1 antagonists do not inhibit human acidosis-induced pain. J. Pain. 18, 526\u2013534 (2017).","journal-title":"J. Pain."},{"key":"76771_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07914-w","volume":"12","author":"G Szylar","year":"2022","unstructured":"Szylar, G. et al. A novel Streptococcus pneumoniae human challenge model demonstrates Treg lymphocyte recruitment to the infection site. Sci. Rep. 12, 3990 (2022).","journal-title":"Sci. Rep."},{"key":"76771_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-252","volume":"13","author":"GT Ray","year":"2013","unstructured":"Ray, G. T., Suaya, J. A. & Baxter, R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect. Dis. 13, 252 (2013).","journal-title":"BMC Infect. Dis."},{"key":"76771_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ofid\/ofw172.145","volume":"3","author":"E Mcginnis","year":"2016","unstructured":"Mcginnis, E., Cammarata, S., Tan, R.-D., Barrett, M. & Tuttle, E. Characteristics of patients hospitalized for acute bacterial skin and skin structure infections (ABSSSI) From 2009 to 2013. Open Forum Infect. Dis. 3, 279 (2016).","journal-title":"Open Forum Infect. Dis."},{"key":"76771_CR29","unstructured":"Neidhardt, F. C. & Curtiss, R. Escherichia Coli and Salmonella: Cellular and Molecular Biology (ASM Press, Washington, D.C, 1996)."},{"key":"76771_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00011-022-01584-0","volume":"71","author":"BM Facchin","year":"2022","unstructured":"Facchin, B. M. et al. Inflammatory biomarkers on an LPS-induced RAW 264.7 cell model: a systematic review and meta-analysis. Inflamm. Res. 71, 741\u2013758 (2022).","journal-title":"Inflamm. Res."},{"key":"76771_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135371","volume":"279","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Application of lipopolysaccharide in establishing inflammatory models. Int. J. Biol. Macromol. 279, 135371 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"76771_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2018.06.014","volume":"159","author":"D van Lier","year":"2019","unstructured":"van Lier, D., Geven, C., Leijte, G. P. & Pickkers, P. Experimental human endotoxemia as a model of systemic inflammation. Biochimie 159, 99\u2013106 (2019).","journal-title":"Biochimie"},{"key":"76771_CR33","doi-asserted-by":"publisher","unstructured":"Hargreaves, K., Dubner R., Brown, F., Flores, C. & Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77\u201388 https:\/\/doi.org\/10.1016\/0304-3959(88)90026-7 (1988).","DOI":"10.1016\/0304-3959(88)90026-7"},{"key":"76771_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.97","volume":"45","author":"BS Park","year":"2013","unstructured":"Park, B. S. & Lee, J.-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 45, e66 (2013).","journal-title":"Exp. Mol. Med."},{"key":"76771_CR35","doi-asserted-by":"publisher","unstructured":"Hoshino, K. et al. Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as theLpsGene Product. J. Immunol. 162, 3749\u20133752 https:\/\/doi.org\/10.4049\/jimmunol.162.7.3749 (1999).","DOI":"10.4049\/jimmunol.162.7.3749"},{"key":"76771_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0022034511400225","volume":"90","author":"A Diogenes","year":"2011","unstructured":"Diogenes, A., Ferraz, C. C. R., Akopian, A. N., Henry, M. A. & Hargreaves, K. M. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J. Dent. Res. 90, 759\u2013764 (2011).","journal-title":"J. Dent. Res."},{"key":"76771_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molimm.2013.07.008","volume":"56","author":"ZA Ibrahim","year":"2013","unstructured":"Ibrahim, Z. A., Armour, C. L., Phipps, S. & Sukkar, M. B. RAGE and TLRs: relatives, friends or neighbours? Mol. Immunol. 56, 739\u2013744 (2013).","journal-title":"Mol. Immunol."},{"key":"76771_CR38","doi-asserted-by":"publisher","unstructured":"Meseguer, V. et al. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat. Commun. 5, 3125 https:\/\/doi.org\/10.1038\/ncomms4125 (2014).","DOI":"10.1038\/ncomms4125"},{"key":"76771_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang, H., Wang, H. & Andersson, U. Targeting Inflammation Driven by HMGB1. Front. Immunol. 11, 484 (2020).","journal-title":"Front. Immunol."},{"key":"76771_CR40","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella, S. et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995\u20131001 (2002).","journal-title":"EMBO Rep."},{"key":"76771_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang, H. et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248\u2013251 (1999).","journal-title":"Science"},{"key":"76771_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1182\/blood-2004-10-3906","volume":"106","author":"C Semino","year":"2005","unstructured":"Semino, C., Angelini, G., Poggi, A. & Rubartelli, A. NK\/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106, 609\u2013616 (2005).","journal-title":"Blood"},{"key":"76771_CR43","doi-asserted-by":"publisher","first-page":"585146","DOI":"10.3389\/fimmu.2020.585146","volume":"11","author":"A Zamyatina","year":"2020","unstructured":"Zamyatina, A. & Heine, H. Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4\/11 mediated inflammatory pathways. Front. Immunol. 11, 585146 (2020).","journal-title":"Front. Immunol."},{"key":"76771_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/intimm\/dxg068","volume":"15","author":"A Pivarcsi","year":"2003","unstructured":"Pivarcsi, A. et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15, 721\u2013730 (2003).","journal-title":"Int. Immunol."},{"key":"76771_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/1744806916688220","volume":"13","author":"A Bort","year":"2017","unstructured":"Bort, A. et al. Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical\/transdermal delivery. Mol. Pain 13, 1744806916688220 (2017).","journal-title":"Mol. Pain"},{"key":"76771_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/imm.12363","volume":"144","author":"A Said","year":"2015","unstructured":"Said, A., Bock, S., M\u00fcller, G. & Weindl, G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology 144, 218\u2013230 (2015).","journal-title":"Immunology"},{"key":"76771_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fimmu.2019.00102","volume":"10","author":"P Kelly","year":"2019","unstructured":"Kelly, P., Meade, K. G. & O\u2019Farrelly, C. Non-canonical inflammasome-mediated IL-1\u03b2 production by primary endometrial epithelial and stromal fibroblast cells is NLRP3 and caspase-4 dependent. Front. Immunol. 10, 102 (2019).","journal-title":"Front. Immunol."},{"key":"76771_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-1-28","volume":"1","author":"TR Neelands","year":"2005","unstructured":"Neelands, T. R., Jarvis, M. F., Han, P., Faltynek, C. R. & Surowy, C. S. Acidification of rat TRPV1 alters the kinetics of capsaicin responses. Mol. Pain 1, 28 (2005).","journal-title":"Mol. Pain"},{"key":"76771_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","volume":"21","author":"M Tominaga","year":"1998","unstructured":"Tominaga, M. et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21, 531\u2013543 (1998).","journal-title":"Neuron"},{"key":"76771_CR50","doi-asserted-by":"publisher","first-page":"15435","DOI":"10.1073\/pnas.93.26.15435","volume":"93","author":"P Cesare","year":"1996","unstructured":"Cesare, P. & McNaughton, P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc. Natl. Acad. Sci. USA 93, 15435\u201315439 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76771_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/35050121","volume":"408","author":"LS Premkumar","year":"2000","unstructured":"Premkumar, L. S. & Ahern, G. P. Induction of vanilloid receptor channel activity by protein kinase C. Nature 408, 985\u2013990 (2000).","journal-title":"Nature"},{"key":"76771_CR52","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.1523\/JNEUROSCI.3721-12.2013","volume":"33","author":"MJM Fischer","year":"2013","unstructured":"Fischer, M. J. M., Btesh, J. & McNaughton, P. A. Disrupting sensitization of transient receptor potential vanilloid subtype 1 inhibits inflammatory hyperalgesia. J. Neurosci. 33, 7407\u20137414 (2013).","journal-title":"J. Neurosci."},{"key":"76771_CR53","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.1073\/pnas.111025298","volume":"98","author":"M Tominaga","year":"2001","unstructured":"Tominaga, M., Wada, M. & Masu, M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. USA 98, 6951\u20136956 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76771_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuroscience.2010.08.003","volume":"170","author":"M Gautam","year":"2010","unstructured":"Gautam, M., Benson, C. J. & Sluka, K. A. Increased response of muscle sensory neurons to decreases in pH after muscle inflammation. Neuroscience 170, 893\u2013900 (2010).","journal-title":"Neuroscience"},{"key":"76771_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-10-2","volume":"10","author":"S-G Kwon","year":"2014","unstructured":"Kwon, S.-G. et al. Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain. Mol. Pain 10, 2 (2014).","journal-title":"Mol. Pain"},{"key":"76771_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","volume":"123","author":"R Rolke","year":"2006","unstructured":"Rolke, R. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123, 231\u2013243 (2006).","journal-title":"Pain"},{"key":"76771_CR57","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cns.12444","volume":"22","author":"DM Lopes","year":"2016","unstructured":"Lopes, D. M. & McMahon, S. B. Ultraviolet radiation on the skin: a painful experience? CNS Neurosci. Ther. 22, 118\u2013126 (2016).","journal-title":"CNS Neurosci. Ther."},{"key":"76771_CR58","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/j.pain.0000000000000134","volume":"156","author":"S Wang","year":"2015","unstructured":"Wang, S., Joseph, J., Ro, J. Y. & Chung, M.-K. Modality-specific mechanisms of protein kinase C-induced hypersensitivity of TRPV1: S800 is a polymodal sensitization site. Pain 156, 931\u2013941 (2015).","journal-title":"Pain"},{"key":"76771_CR59","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.1523\/JNEUROSCI.0278-14.2014","volume":"34","author":"L Li","year":"2014","unstructured":"Li, L., Hasan, R. & Zhang, X. The basal thermal sensitivity of the TRPV1 ion channel is determined by PKC\u03b2II. J. Neurosci. 34, 8246\u20138258 (2014).","journal-title":"J. Neurosci."},{"key":"76771_CR60","doi-asserted-by":"publisher","first-page":"E395","DOI":"10.1152\/ajpendo.00477.2009","volume":"298","author":"AC Newton","year":"2010","unstructured":"Newton, A. C. Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 298, E395\u2013E402 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"76771_CR61","doi-asserted-by":"publisher","first-page":"12480","DOI":"10.1073\/pnas.2032100100","volume":"100","author":"G Bhave","year":"2003","unstructured":"Bhave, G. et al. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA 100, 12480\u201312485 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76771_CR62","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.4049\/jimmunol.1600702","volume":"197","author":"Z Yao","year":"2016","unstructured":"Yao, Z. et al. Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. J. Immunol. 197, 2390\u20132399 (2016).","journal-title":"J. Immunol."},{"key":"76771_CR63","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.4049\/jimmunol.1004087","volume":"187","author":"M Lu","year":"2011","unstructured":"Lu, M. & Munford, R. S. The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J. Immunol. 187, 3314\u20133320 (2011).","journal-title":"J. Immunol."},{"key":"76771_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175703","volume":"948","author":"W Kong","year":"2023","unstructured":"Kong, W. et al. Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer. Eur. J. Pharmacol. 948, 175703 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"76771_CR65","doi-asserted-by":"publisher","DOI":"10.1177\/1744806918788648","volume":"14","author":"Y Guo","year":"2018","unstructured":"Guo, Y. et al. Therapeutic potential of Pak1 inhibition for pain associated with cutaneous burn injury. Mol. Pain 14, 1744806918788648 (2018).","journal-title":"Mol. Pain"},{"key":"76771_CR66","doi-asserted-by":"publisher","unstructured":"Fullerton, J. N., Segre, E., De Maeyer, R. P. H., Maini, A. A. N. & Gilroy, D. W. Intravenous endotoxin challenge in healthy humans: an experimental platform to investigate and modulate systemic inflammation. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53913 (2016).","DOI":"10.3791\/53913"},{"key":"76771_CR67","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0024-3205(69)90283-5","volume":"8","author":"AH Bretag","year":"1969","unstructured":"Bretag, A. H. Synthetic interstitial fluid for isolated mammalian tissue. Life Sci. 8, 319\u2013329 (1969).","journal-title":"Life Sci."},{"key":"76771_CR68","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/j.pain.0000000000003503","volume":"166","author":"FJ Resch","year":"2025","unstructured":"Resch, F. J. et al. Human cold pain: a randomized crossover trial. Pain 166, 1406\u20131417 (2025).","journal-title":"Pain"},{"key":"76771_CR69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1753425918819754","volume":"25","author":"D Kiers","year":"2019","unstructured":"Kiers, D. et al. Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia model. Innate Immun. 25, 34\u201345 (2019).","journal-title":"Innate Immun."},{"key":"76771_CR70","unstructured":"Mjalli, A. M. M., Andrews, R. C., Shen, J. M. & Rothlein, R. Rage antagonists as agents to reverse amyloidosis and diseases associated therewith. WIPO WO2005000295A1 (2005)."},{"key":"76771_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","volume":"584","author":"T Kawamoto","year":"2008","unstructured":"Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y. & Kimura, H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharmacol. 584, 40\u201348 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"76771_CR72","doi-asserted-by":"publisher","unstructured":"Gavva, N. R. et al. AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(23-dihydrobenzo[b][14] dioxin-6-yl)acrylamide] a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties. J. Pharmacol. Exp. Ther. 313, 474\u2013484 https:\/\/doi.org\/10.1124\/jpet.104.079855 (2005).","DOI":"10.1124\/jpet.104.079855"},{"key":"76771_CR73","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3048-18.2019","volume":"39","author":"S Heber","year":"2019","unstructured":"Heber, S. et al. A human TRPA1-specific pain model. J. Neurosci. 39, 3845\u20133855 (2019).","journal-title":"J. Neurosci."},{"key":"76771_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado3498","volume":"10","author":"S Heber","year":"2024","unstructured":"Heber, S. et al. Human heat sensation: a randomized crossover trial. Sci. Adv. 10, eado3498 (2024).","journal-title":"Sci. Adv."},{"key":"76771_CR75","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious, S. A. Sample size of 12 per group rule of thumb for a pilot study. Pharm. Stat. 4, 287\u2013291 (2005).","journal-title":"Pharm. Stat."},{"key":"76771_CR76","first-page":"149","volume":"2","author":"EJ Williams","year":"1949","unstructured":"Williams, E. J. Experimental designs balanced for the estimation of residual effects of treatments. Aust. J. Sci. Res. A Phys. Sci. 2, 149 (1949).","journal-title":"Aust. J. Sci. Res. A Phys. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76771-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76771-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76771-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:02:27Z","timestamp":1791158547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76771-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76771"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76771-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10461"}}